Tevogen Bio Holdings Inc. (TVGN)

Tevogen Bio Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	10.13	15.03	22.53	4.44	0.95
Research & Development	11.05	11.11	31.03	4.4	-
Total Operating Expenses	21.19	26.14	53.56	8.84	0.95
Operating Income	-21.19	-26.14	-53.56	-8.84	-0.95
Interest Income	-	-	-	-	4.95
Interest Expense	-0.24	-0.2	-0.18	-1.21	-
Other Non-Operating Income (Expense)	0.07	0.06	40.02	-50.43	0.41
Total Non-Operating Income (Expense)	-0.17	-0.13	39.84	-51.63	5.36
Pretax Income	-21.35	-26.28	-13.73	-60.48	4.41
Net Income	-21.35	-26.28	-13.73	-60.48	4.41
Net Income to Common	-21.94	-26.83	-10.27	-60.48	4.41
Shares Outstanding (Basic)	3	3	3	0	1
Shares Outstanding (Diluted)	3	3	3	0	1
Shares Change (YoY)	10.96%	13.17%	492.57%	-1.98%	-
EPS (Basic)	-6.69	-8.08	-3.50	-122.00	-43.50
EPS (Diluted)	-6.69	-8.08	-3.50	-122.00	-43.50
Free Cash Flow	-11.75	-12.39	-12	-8.3	-0.22
Free Cash Flow Per Share	-3.58	-3.73	-4.09	-16.77	-0.43
EBITDA	-20.72	-25.63	-53.16	-8.46	-0.95
EBIT	-21.19	-26.14	-53.56	-8.84	-0.95

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error